• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory & Compliance
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Special Content
    • Special Reports
    • In-Depth Coverage
    • DeviceTalks
  • Podcasts
    • MassDevice Fast Five
    • DeviceTalks Weekly
    • OEM Talks
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Resources
    • About MassDevice
    • DeviceTalks
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices
Home » Hips: Bellwether DePuy trials for recalled ASR hip implants to begin next year

Hips: Bellwether DePuy trials for recalled ASR hip implants to begin next year

August 8, 2012 By MassDevice staff

hip implant x-ray

The 1st patient injury lawsuits following the high-profile recall of Johnson & Johnson (NYSE:JNJ) subsidiary DePuy Orthopaedics’ metal-on-metal hip implants are set to begin next year.

U.S. District Judge David Katz ordered both plaintiffs and defendants in the multi-district litigation against DePuy to each select "select 4 ASR revision cases as bellwether trial candidates" to move forward with in 2013, according to the court order.

Each side has until August 8 to select which cases it wants to pursue, and neither party may pick lawsuits brought by patients that had both hips repaired with the ASR implants.

Lawsuits against DePuy began piling up in June 2010 when a a Florida woman accused the company of knowing about the device’s problems but failed to warn physicians. That suit was followed days later by 3 more from California residents who all had to have revision surgery after the implant partially detached from their hip sockets.

Warsaw, Ind.-based DePuy Orthopedics pulled its ASR XL Acetabular and ASR Hip Resurfacing systems off the market in August 2010 after receiving reports that a higher-than-normal number of patients required surgeries to correct or remove defective implants. More than 96,000 patients were been affected by the massive global recall.

The recall, was prompted by new data from the National Joint Registry of England and Wales showing "a 5-year revision rate of approximately 12% for the ASR Hip Resurfacing System and approximately 13% for the ASR XL Acetabular System," according to a DePuy press release announcing the recall.

More than 1,100 patients have since joined a multi-district litigation consolidated in the Lone Star State under Judge James Kinkeade.

DePuy and its accusers have until November 1 to conduct any depositions of the plaintiffs, the implanting surgeons, the explanting surgeons and "one fact witness per side as necessary to determine whether the case should be designated as a bellwether trial candidate case," according to the order.

Each side will then have until December 1, 2012 to tell the court which of the 8 proposed cases should stand proceed. If the parties can’t agree on the cases by December 15, the court will select them.

The first bellwether case will begin on May 6, 2013, and the second will follow on July 8, 2013, according to court documents.

Filed Under: Legal News, News Well Tagged With: depuysynthes, Hips, Johnson and Johnson

More recent news

  • GT Medical raises $53M to support brain tumor treatment
  • Imperative Care, Proximie partner to develop surgical robot to treat stroke
  • Carlsmed launches IPO roadshow
  • Varian introduces IntelliBlate for image-guided cancer therapy in Europe
  • Henry Schein CEO Stanley M. Bergman to retire

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >

MEDTECH 100 Stock INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy